BRPI0707203B8 - compostos derivados de indoloquinoxalina úteis para o tratamento de infecções virais, método para preparar os compostos, e, composição farmacêutica - Google Patents
compostos derivados de indoloquinoxalina úteis para o tratamento de infecções virais, método para preparar os compostos, e, composição farmacêuticaInfo
- Publication number
- BRPI0707203B8 BRPI0707203B8 BRPI0707203A BRPI0707203A BRPI0707203B8 BR PI0707203 B8 BRPI0707203 B8 BR PI0707203B8 BR PI0707203 A BRPI0707203 A BR PI0707203A BR PI0707203 A BRPI0707203 A BR PI0707203A BR PI0707203 B8 BRPI0707203 B8 BR PI0707203B8
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- preparing
- treatment
- pharmaceutical composition
- indoloquinoxaline
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- NXOVZLREWXNIDP-UHFFFAOYSA-N 7h-pyrazino[2,3-c]carbazole Chemical compound N1=CC=NC2=C3C4=CC=CC=C4NC3=CC=C21 NXOVZLREWXNIDP-UHFFFAOYSA-N 0.000 title 1
- 208000036142 Viral infection Diseases 0.000 title 1
- 230000009385 viral infection Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0600134-1 | 2006-01-23 | ||
SE0600134A SE529777C2 (sv) | 2006-01-23 | 2006-01-23 | Nya föreningar och användning därav |
PCT/SE2007/050033 WO2007084073A1 (en) | 2006-01-23 | 2007-01-22 | Novel compounds and use thereof |
Publications (4)
Publication Number | Publication Date |
---|---|
BRPI0707203A2 BRPI0707203A2 (pt) | 2011-04-26 |
BRPI0707203B1 BRPI0707203B1 (pt) | 2020-11-10 |
BRPI0707203B8 true BRPI0707203B8 (pt) | 2020-12-08 |
BRPI0707203C1 BRPI0707203C1 (pt) | 2021-05-25 |
Family
ID=38287919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0707203A BRPI0707203C1 (pt) | 2006-01-23 | 2007-01-22 | compostos derivados de indoloquinoxalina úteis para o tratamento de infecções virais, método para preparar os compostos, e, composição farmacêutica |
Country Status (24)
Country | Link |
---|---|
US (1) | US8076341B2 (pt) |
EP (1) | EP1976853B1 (pt) |
JP (1) | JP5190379B2 (pt) |
CN (1) | CN101374845B (pt) |
AR (1) | AR059149A1 (pt) |
AT (1) | ATE506365T1 (pt) |
AU (1) | AU2007206092B2 (pt) |
BR (1) | BRPI0707203C1 (pt) |
CA (1) | CA2637417C (pt) |
CY (1) | CY1112596T1 (pt) |
DE (1) | DE602007014008D1 (pt) |
DK (1) | DK1976853T3 (pt) |
ES (1) | ES2365423T3 (pt) |
HR (1) | HRP20110534T1 (pt) |
IL (1) | IL192820A (pt) |
NZ (1) | NZ569840A (pt) |
PL (1) | PL1976853T3 (pt) |
PT (1) | PT1976853E (pt) |
RS (1) | RS51933B (pt) |
RU (1) | RU2437887C2 (pt) |
SE (1) | SE529777C2 (pt) |
SI (1) | SI1976853T1 (pt) |
WO (1) | WO2007084073A1 (pt) |
ZA (1) | ZA200806315B (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602008001795D1 (de) | 2008-04-30 | 2010-08-26 | Univ Duisburg Essen | IndolÄ2,3-bÜ-, IndenÄ1,2-bÜ- und IndenÄ2,1-bÜpyridoÄ2,3-fÜ Quinoxalin-3-Carboxylsäuren und Ester, Verfahren zu ihrer Herstellung und ihre Verwendung als Antivirus- und Antitumormittel |
EP2489354A1 (en) * | 2011-02-18 | 2012-08-22 | Vironova AB | Pharmaceutical formulation of B220 for topical treatment of herpes |
CN105061432B (zh) * | 2015-07-16 | 2017-09-29 | 河北大学 | 6H‑吲哚[2,3‑b]喹喔啉衍生物、药物组合物及其制备和应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8600260D0 (sv) * | 1986-01-21 | 1986-01-21 | Lundblad Leif | Substituerade indolokinoxaliner |
SE8600261D0 (sv) * | 1986-01-21 | 1986-01-21 | Lundblad Leif | Indolokinoxaliner med substituenter i 6-position som innehaller cykliska grupper |
SE527639C2 (sv) * | 2004-06-17 | 2006-05-02 | Oxypharma Ab | Alkylsubstituerade indolokinoxaliner |
-
2006
- 2006-01-23 SE SE0600134A patent/SE529777C2/sv not_active IP Right Cessation
-
2007
- 2007-01-22 NZ NZ569840A patent/NZ569840A/en not_active IP Right Cessation
- 2007-01-22 ES ES07709426T patent/ES2365423T3/es active Active
- 2007-01-22 RS RS20110304A patent/RS51933B/en unknown
- 2007-01-22 AR ARP070100274A patent/AR059149A1/es not_active Application Discontinuation
- 2007-01-22 DK DK07709426.6T patent/DK1976853T3/da active
- 2007-01-22 US US12/161,081 patent/US8076341B2/en not_active Expired - Fee Related
- 2007-01-22 CA CA2637417A patent/CA2637417C/en not_active Expired - Fee Related
- 2007-01-22 RU RU2008134509/04A patent/RU2437887C2/ru active
- 2007-01-22 AT AT07709426T patent/ATE506365T1/de active
- 2007-01-22 DE DE602007014008T patent/DE602007014008D1/de active Active
- 2007-01-22 ZA ZA200806315A patent/ZA200806315B/xx unknown
- 2007-01-22 SI SI200730657T patent/SI1976853T1/sl unknown
- 2007-01-22 EP EP07709426A patent/EP1976853B1/en active Active
- 2007-01-22 JP JP2008551228A patent/JP5190379B2/ja not_active Expired - Fee Related
- 2007-01-22 AU AU2007206092A patent/AU2007206092B2/en not_active Ceased
- 2007-01-22 BR BRPI0707203A patent/BRPI0707203C1/pt not_active IP Right Cessation
- 2007-01-22 WO PCT/SE2007/050033 patent/WO2007084073A1/en active Application Filing
- 2007-01-22 PL PL07709426T patent/PL1976853T3/pl unknown
- 2007-01-22 CN CN2007800028861A patent/CN101374845B/zh not_active Expired - Fee Related
- 2007-01-22 PT PT07709426T patent/PT1976853E/pt unknown
-
2008
- 2008-07-15 IL IL192820A patent/IL192820A/en active IP Right Grant
-
2011
- 2011-07-18 CY CY20111100698T patent/CY1112596T1/el unknown
- 2011-07-18 HR HR20110534T patent/HRP20110534T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2397168C2 (ru) | Производные тиофена в качестве ингибиторов снк 1 | |
BR122012009489B8 (pt) | processo para produzir 2-etóxi-1-{[2-(5-oxo-4,5-diidro-1,2,4-oxadiazol-3-il)bifenil-4-il]metil}-1h-benzimidazol-7-carboxilato de (5-metil-2-oxo-1,3-dioxol-4-il)metila ou um sal do mesmo, composição farmacéutica, e, uso | |
BRPI0607600A2 (pt) | derivados de 4-oxoquinazolin-3-il-benzamida para o tratamento de doenças relacionadas com citocina | |
BRPI0608732A2 (pt) | composto ou um sal, hidrato, solvato, complexo ou pró-droga farmaceuticamente aceitável do mesmo, sal de um composto, processo para a preparação de um composto, uso de um composto, composição farmacêutica, e, produto | |
BRPI0718714B8 (pt) | arilamidas substituídas por tiazol e oxazol, seu uso e composição farmacêutica que as compreende | |
AR062886A1 (es) | Compuestos de tiazol pirazolopirimidina, composicion farmaceutica que lo comprende y su uso para preparar un medicamento | |
PE20070218A1 (es) | COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA | |
PE20090060A1 (es) | ANALOGOS DE IMIDAZOLOPIRIMIDINA Y SU USO COMO INHIBIDORES DE PI3 CINASA Y mTOR | |
BRPI0607796A2 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparação e uso do mesmo, e, composição farmacêutica | |
BR112014003237A2 (pt) | compostos de indazol, composições e métodos de uso | |
BRPI0614168A2 (pt) | Composto ou um sal, hidrato, solvato, isoforma, tautômero, isômero óptico farmaceuticamente aceitável ou uma combinação dos mesmos, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psquiátricos, uso de um composto, e, processo para a preparação de um composto | |
ATE457988T1 (de) | A2a-adenosin-rezeptor-antagonisten | |
BRPI0510604B8 (pt) | composto 4-fenilamino-quinazolin-6-il-amida, seu uso e composição farmacêutica que o compreende composto 4-fenilamino-quinazolin-6-il-amida, seu uso e composição farmacêutica que o compreende | |
PE20090276A1 (es) | Compuestos derivados de imidazoquinolina como moduladores de tlr7 | |
BRPI0707491B8 (pt) | compostos úteis como agentes moduladores de receptores de mineralocorticóides, os referidos agentes compreendendo os mesmos e composições farmacêuticas | |
BRPI0518360A2 (pt) | composto e sais farmaceuticamente aceitÁveis do mesmo, composiÇço farmacÊutica, uso de um composto, e, processo para preparar um composto ou um sal farmaceuticamente aceitÁvel do mesmo | |
BRPI0817096B8 (pt) | análogo de tiazolidinodiona e composição farmacêutica que o compreende | |
SE0402735D0 (sv) | Novel compounds | |
AR056574A1 (es) | Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso | |
BRPI0408353A (pt) | composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto | |
AR053364A1 (es) | Compuesto de 1h-imidazo 84,5-c) piridin -2- ilo, composicion farmaceutica que lo comprende, proceso para prepararla y su uso para preparar un medicamento para tratamiento de cancer o artritis | |
AR051795A1 (es) | Derivados de hidantoina inhibidores de metaloproteinasas | |
BRPI0809981A2 (pt) | Compostos, processo de fabricação destes, composição farmacêutica que os contém, método de tratamento e/ou prevenção de doenças que são associadas a modulação de receptores de sst subtipo 5 e uso dos compostos. | |
BRPI0906444A8 (pt) | compostos de 4-piridinona e seu uso para câncer | |
RU2015125591A (ru) | БЕНЗИЛСУЛЬФОНАМИДНЫЕ ПРОИЗВОДНЫЕ КАК МОДУЛЯТОРЫ RORc |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: VIRONOVA HERPES AB (SE) |
|
B25G | Requested change of headquarter approved |
Owner name: VIRONOVA HERPES AB (SE) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/11/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REF. RPI 2601 DE 10/11/2020 QUANTO AO INVENTOR. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/01/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 16A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2706 DE 16-11-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |